Aequus Pharmaceuticals PEG Ratio

Aequus Pharmaceuticals (AQSZF) currently reports a PEG ratio of -1.95. That is below the sector sector average of 10.01. Use the charts on this page to explore Aequus Pharmaceuticals's PEG ratio history and peer comparisons.

Aequus Pharmaceuticals's PEG ratio of -1.95 is lower than the its sector sector average of 10.01. That is roughly 119.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Aequus Pharmaceuticals's market price to a fundamental measure such as earnings, sales, or book value. At -1.95, AQSZF can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -1.95, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 10.01. From there, open related valuation or income-statement pages for Aequus Pharmaceuticals, and consider following AQSZF for alerts when major investors trade the stock.